ANGIOGENEZA UZ UPORABU MATIČNIH STANICA IZ POSTELJICE

• 收藏
• 分享

专利权人:

Anthrogenesis Corporation

发明人:

Abbot, Stewart,Edinger, James,Francki, Aleksander,Hariri, Robert J.,Jankovic, Vladimir,Kaplunovsky, Aleksandr,Labazzo, Kristen,Law, Eric,Padliya, Neerav,Paredes, Jennifer,Wang, Jia-Lun

申请号：

HRP20161350

公开号：

HRP20161350T1

申请日:

2016.10.17

申请国别(地区):

HR

年份:

2016

代理人:

摘要：

The invention provides a population of placental-derived adherent cells that are CD10+, CD34-, CD105+, and CD200+ for use in a method for treatment of an individual having a disease or injury of the heart or circulatory system. Said placental-derived adherent cells may additionally be one or more of CD45-, CD90+, or OCT-4+.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/